NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) - ANVISA Registration 80464810535

Access comprehensive regulatory information for NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80464810535 and manufactured by GETEIN BIOTECH INC.. The registration is held by ARGOSLAB DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT IRELAND DIAGNOSTICS DIVISION, LABTEST DIAGNOSTICA S/A, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
80464810535
Registration Details
ANVISA Registration Number: 80464810535
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

80464810535

25351131794201709

09377976000152

Company Information

China
PT: CHINA, REPÚBLICA POPULAR

Dates and Status

Oct 02, 2017

VIGENTE

09/18/2025 19:00:01